![]() Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. | Creyon Bio Creyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs). | ||||
Founding Date | Founding Date 2016 | Founding Date 2003 | Founding Date 2018 | Founding Date 2013 | Founding Date 2019 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Berlin, DE HQ | Locations Emeryville, US HQ Sao Paulo, BR | Locations Seattle, US HQ Cambridge, US South San Francisco, US | Locations Cambridge, GB HQ | Locations Carlsbad, US HQ Bengaluru, IN Durham, US |
Employees | Employees 138% increase | Employees 1,0031% decrease | Employees 19441% decrease | Employees 1192% decrease | Employees 522% increase |
Financial | |||||
Net income | Net income N/A | Net income ($543.4m) (FY, 2022) | Net income ($244.2m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 34m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 10m (over 7 years ago) | Latest funding round $ 40m (about 4 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 551.9m | Total funding raised $ 700m | Total funding raised $ 11.3m | Total funding raised $ 40m |

Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation.
View companySana Biotechnology is a company specializing in cell and gene therapy.
View companyNuclera is a company that specializes in DNA synthesis.
View companyCreyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs).
View company